Iodine-131 (I-131) is a radioactive isotope of iodine used in nuclear medicine and radiopharmacology. It is used to diagnose and treat a variety of conditions, including thyroid cancer, hyperthyroidism, and Graves' disease. I-131 is also used to treat certain types of cancer, such as lymphoma and neuroblastoma. It is administered orally, intravenously, or by inhalation. The radiation emitted by I-131 is absorbed by the body and used to destroy cancer cells. I-131 is produced in nuclear reactors and cyclotrons. It is then purified and formulated into a variety of products, such as capsules, solutions, and suspensions. These products are then distributed to hospitals, clinics, and other healthcare facilities. The I-131 market is highly regulated, with strict safety and quality standards in place. The market is also subject to fluctuations in supply and demand, as well as changes in the cost of production. Some companies in the I-131 market include GE Healthcare, Mallinckrodt Pharmaceuticals, Jubilant Radiopharma, and Bracco Diagnostics. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
